MNKD

MannKind (MNKD) Stock: Long Road Ahead, but the Fights Not Over!
  • MannKind (MNKD) Stock: Long Road Ahead, but the Fights Not Over!

MannKind (MNKD) Stock: Long Road Ahead, but the Fights Not Over!

By |August 15th, 2016|

MannKind Corporation (NASDAQ: MNKD)

In the market, there are few stocks that can invoke quite as much emotion among investors as MannKind Corporation. There’s good reason for this. The truth is that there’s a strong case for both the bullish and bearish side opinions. At this point, we all know why those opinions are there. […]

MannKind (MNKD) Stock: Don't Miss This Opportunity
  • MannKind (MNKD) Stock: Don't Miss This Opportunity

MannKind (MNKD) Stock: Don’t Miss This Opportunity

By |June 29th, 2016|

MannKind Corporation (NASDAQ: MNKD)

MannKind has had an incredibly hard time in the market over the past year or so, and for good reason. The first launch of the company’s flagship product, Afrezza, simply didn’t go well. So, I can understand why many investors and traders would be hesitant to get involved in the stock. […]

MannKind (MNKD) Stock: Big Gains Ahead!
  • MannKind (MNKD) Stock: Big Gains Ahead!

MannKind (MNKD) Stock: Big Gains Ahead!

By |June 22nd, 2016|

MannKind Corporation (NASDAQ: MNKD)

MannKind has had a rough time over the past year, and for good reason. The company contracted with a competitor for the launch of its flagship product. Unfortunately, that didn’t work out so well. Nonetheless, they are moving forward with the second Afrezza launch, and things are looking much better. Today, […]

MannKind (MNKD) Stock: CEO Abilities Called Into Question
  • MannKind (MNKD) Stock: CEO Abilities Called Into Question

MannKind (MNKD) Stock: CEO Abilities Called Into Question

By |April 27th, 2016|

MannKind Corporation (NASDAQ: MNKD)

MannKind is having an incredibly hard day in the market today, and for good reason. On a conference call last night, Matt Pfeffer, the CEO of the company raised questions among investors with regard to his level of financial literacy. Today, we’ll talk about how these questions were raised, how the […]

MannKind (MNKD) Stock: Get Ready for Lift Off
  • MannKind (MNKD) Stock: Get Ready for Lift Off

MannKind (MNKD) Stock: Get Ready for Lift Off

By |April 12th, 2016|

MannKind Corporation (NASDAQ: MNKD)
MannKind has been having an incredibly rough time in the market as of late. However, that seems to be changing, and in a big way. Yesterday, the stock gained more than 25% and gains are continuing today. So, what’s causing the upward movement? Well, the simple answer is speculation with regard […]

MannKind (MNKD) Stock Is Soaring: Will It Continue?
  • MannKind (MNKD) Stock Is Soaring: Will It Continue?

MannKind (MNKD) Stock Is Soaring: Will It Continue?

By |March 17th, 2016|

MannKind Corporation (NASDAQ: MNKD)

MannKind is having a great time in the market today. For many, the gains are a complete surprise. After all, the company recently reported its earnings, showing a far wider than expected loss in Q4. Nonetheless, the bulls are out to play today. Below, we’ll talk about why MNKD earnings were […]

MannKind (MNKD) Stock is for Pure Speculation
  • MannKind (MNKD) Stock is for Pure Speculation

MannKind (MNKD) Stock is for Pure Speculation

By |February 24th, 2016|

MannKind Corp (NASDAQ: MNKD)

There’s a lot of buzz online surrounding small biotech company MannKind. Perhaps it has to do with the stocks eye-popping 95% depreciation in its stock price, going from a high of $20 a decade ago to $1 today. Or perhaps it has to do with the promise of a novel diabetes […]

MannKind (MNKD) Investors: This Petition Is For You!
  • MannKind (MNKD) Investors: This Petition Is For You!

MannKind (MNKD) Investors: This Petition Is For You!

By |January 8th, 2016|

MannKind Corporation (NASDAQ: MNKD)

CNA Finance recently launched a petition that was created to support MannKind investors that have lost money as a result of the alleged malicious acts of Sanofi. If you are one of these investors, click here to sign the petition. Today, we’ll talk about why Sanofi is in the wrong, what […]

MannKind (MNKD) Stock Creates a Strong Opportunity
  • MannKind (MNKD) Stock Creates a Strong Opportunity

MannKind (MNKD) Stock Creates a Strong Opportunity

By |January 5th, 2016|

MannKind Corporation (NASDAQ: MNKD)

MannKind is having a rough day in the market today, and while many are ostracizing the stock, I believe that it is presenting quite the opportunity. The reality is that MNKD has done what I’ve thought they should do for quite some time now. MannKind cut ties with Sanofi! Today, we’ll […]

MannKind Corporation (MNKD) Gets Destroyed By Earnings
  • MannKind Corporation (MNKD) Gets Destroyed By Earnings

MannKind Corporation (MNKD) Gets Destroyed By Earnings

By |November 10th, 2015|

MannKind Corporation (NASDAQ: MNKD)
MannKind has been a very interesting stock to follow this year. After receiving FDA approval for Afrezza, the company’s stock climbed dramatically. However, after sales proved to be lackluster at best, the stock has been tanking. Yesterday, MNKD released its Q3 earnings report, ultimately adding insult to injury. Today, we’ll take […]